BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MUC16, CA125, CA-125
331 results:

  • 1. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
    Tan Y; Liu R; Xue JW; Feng Z
    Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
    Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
    J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of natural killer cells injection combined with XELOX chemotherapy in postoperative patients with stage III colorectal cancer in China: a prospective randomised controlled clinical trial study protocol.
    Geng S; Yu X; Yu S
    BMJ Open; 2024 Mar; 14(3):e080377. PubMed ID: 38531576
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
    Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
    J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
    Yu K; Fang X
    Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Preoperative CA 19-9 Predicts Disease Progression in colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
    Fackche NT; Schmocker RK; Nudotor R; Kubi B; Cloyd JM; Grotz TE; Fournier KF; Dineen SP; Veerapong J; Baumgartner JM; Clarke CN; Patel SH; Wilson GC; Lambert LA; Pokrzywa C; Abbott DE; Lee B; Staley CA; Zaidi MY; Johnston FM; Greer JB
    Ann Surg Oncol; 2024 May; 31(5):3314-3324. PubMed ID: 38310181
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
    Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
    Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
    Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
    Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
    Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
    He Y; He X; Zhou Y; Luo S
    BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Early Screening of colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
    Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
    Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer.
    Tejerina-Miranda S; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Reviejo AJ; Pedrero M; Pingarrón JM; Barderas R; Campuzano S
    Int J Biol Macromol; 2023 Sep; 248():125996. PubMed ID: 37499706
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
    Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
    Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Minimally invasive surgery versus laparotomy of nonmetastatic pT4a colorectal cancer: a propensity score analysis.
    Guo HL; Chen JY; Tang YZ; Zeng QL; Jian QL; Li MZ; He YL; Wu WH
    Int J Surg; 2023 Nov; 109(11):3294-3302. PubMed ID: 37462996
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk factors for postoperative recurrence in patients with stage II colorectal cancer.
    Xiong ZZ; Xie MH; Li XZ; Jin LY; Zhang FX; Yin S; Chen HX; Lian L
    BMC Cancer; 2023 Jul; 23(1):658. PubMed ID: 37452325
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in colorectal cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The value of ca125 in predicting acute complicated colonic diverticulitis.
    Zager Y; Khalilieh S; Mansour A; Cohen K; Nadler R; Anteby R; Ram E; Horesh N; Nachmany I; Gutman M; Berger Y
    Int J Colorectal Dis; 2023 Jun; 38(1):182. PubMed ID: 37389666
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
    Rong W; Shao S; Pu Y; Ji Q; Zhu H
    Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.